Clincosm LogoSign in Get a demo

EYE-MARKER: Characterization of Potential Biomarkers of Eye Disease and Vision

Sponsor
Association for Innovation and Biomedical Research on Light and Image (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02500862
Collaborator
(none)
100
Enrollment
1
Location
87
Duration (Months)
1.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Characterize potential biomarkers of sight-threatening eye diseases based on the information acquired in clinical practice at CEC, AIBILI

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This is a registry study. Only patients followed under the clinical practice at AIBILI Clinical Trial Centre, and with a signed informed consent form will be included.

    Based on the clinical information collected under the clinical practice, and based on patients' characteristics, scientific questions will be raised and data will be collected and analysed accordingly.

    Any procedure performed under clinical practice that may allow for the characterization of the disease and/or for the identification of potential biomarkers will be collected and analysed.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    100 participants
    Observational Model:
    Other
    Time Perspective:
    Other
    Official Title:
    Characterization of Potential Biomarkers of Eye Disease and Vision Loss.
    Study Start Date :
    Sep 1, 2015
    Actual Primary Completion Date :
    Dec 1, 2019
    Anticipated Study Completion Date :
    Dec 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Characterize potential biomarkers of sight-threatening eye diseases based on the information acquired in clinical practice at CEC, AIBILI. [10 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Any patient followed under the normal clinical practice at AIBILI Clinical Trial Centre, and with a AIBILI signed informed consent form for data collection, Imp. 11-7-2 "Consentimento Informado para tratamento de dados".
    Exclusion criteria:
    • None

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CEC Coimbra Portugal 3000-548

    Sponsors and Collaborators

    • Association for Innovation and Biomedical Research on Light and Image

    Investigators

    • Principal Investigator: Maria L Ribeiro, MsC, Association for Innovation and Biomedical Research on Light and Image

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Association for Innovation and Biomedical Research on Light and Image
    ClinicalTrials.gov Identifier:
    NCT02500862
    Other Study ID Numbers:
    • 4C-2015-08
    First Posted:
    Jul 17, 2015
    Last Update Posted:
    Feb 15, 2022
    Last Verified:
    Feb 1, 2022
    Keywords provided by Association for Innovation and Biomedical Research on Light and Image
    Eye
    Imaging
    Additional relevant MeSH terms:
    Eye Diseases

    Study Results

    No Results Posted as of Feb 15, 2022